Advertisement

Genetic Abnormalities of Surfactant Metabolism

  • Lawrence M. Nogee
  • Susan E. Wert
Part of the Molecular Pathology Library book series (MPLB, volume 1)

Abstract

Pulmonary surfactant is the complex mixture of lipids and proteins needed to reduce alveolar surface tension at the air-liquid interface and prevent alveolar collapse at the end of expiration. It has been recognized for almost 50 years that a deficiency in surfactant production due to pulmonary immaturity is the principal cause of the respiratory distress syndrome (RDS) observed in prematurely born infants.1 Secondary surfactant deficiency due to injury to the cells involved in its production and functional inactivation of surfactant is also important in the pathophysiology of acute respiratory distress syndrome (ARDS) observed in older children and adults.2,3 In the past 15 years, it has been recognized that surfactant deficiency may result from genetic mechanisms involving mutations in genes encoding critical components of the surfactant system or proteins involved in surfactant metabolism.4,5 Although rare, these single gene disorders provide important insights into normal surfactant metabolism and into the genes in which frequently occurring allelic variants may be important in more common pulmonary diseases.

Keywords

Interstitial Lung Disease Surfactant Protein Lamellar Body Pulmonary Surfactant Pulmonary Alveolar Proteinosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 1959;97(5, Part 1):517–523.PubMedGoogle Scholar
  2. 2.
    Gregory TJ, Longmore WJ, Moxley MA, et al. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 1991;88(6):1976–1981.PubMedCrossRefGoogle Scholar
  3. 3.
    Greene KE, Wright JR, Steinberg KP, et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999;160(6):1843–1850.PubMedGoogle Scholar
  4. 4.
    Nogee LM. Genetic mechanisms of surfactant deficiency. Biol Neonate 2004;85(4):314–318.PubMedCrossRefGoogle Scholar
  5. 5.
    Whitsett JA, Wert SE, Xu Y. Genetic disorders of surfactant homeostasis. Biol Neonate 2005;87(4):283–287.PubMedCrossRefGoogle Scholar
  6. 6.
    Weaver TE, Na CL, Stahlman M. Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin Cell Dev Biol 2002;13(4):263–270.PubMedCrossRefGoogle Scholar
  7. 7.
    Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1998;1408(2–3):79–89.PubMedGoogle Scholar
  8. 8.
    Ridsdale R, Post M. Surfactant lipid synthesis and lamellar body formation in glycogen-laden type II cells. Am J Physiol Lung Cell Mol Physiol 2004;287(4):L743–L751.PubMedCrossRefGoogle Scholar
  9. 9.
    Ridsdale R, Tseu I, Wang J, et al. CTP:phosphocholine cytidylyltransferase alpha is a cytosolic protein in pulmonary epithelial cells and tissues. J Biol Chem 2001;276(52):49148–49155.PubMedCrossRefGoogle Scholar
  10. 10.
    Rooney SA, Young SL, Mendelson CR. Molecular and cellular processing of lung surfactant. FASEB J 1994;8(12):957–967.PubMedGoogle Scholar
  11. 11.
    McCoy DM, Fisher K, Robichaud J, et al. Transcriptional regulation of lung cytidylyltransferase in developing transgenic mice. Am J Respir Cell Mol Biol 2006;35(3):394–402.PubMedCrossRefGoogle Scholar
  12. 12.
    Mulugeta S, Gray JM, Notarfrancesco KL, et al. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002;277(25):22147–22155.PubMedCrossRefGoogle Scholar
  13. 13.
    Shulenin S, Nogee LM, Annilo T, et al. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004;350(13):1296–1303.PubMedCrossRefGoogle Scholar
  14. 14.
    Floros J, Hoover RR. Genetics of the hydrophilic surfactant proteins A and D. Biochim Biophys Acta 1998;1408(2–3):312–322.PubMedGoogle Scholar
  15. 15.
    Crouch E, Wright JR. Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol 2001;63:521–554.PubMedCrossRefGoogle Scholar
  16. 16.
    Hawgood S, Poulain FR. The pulmonary collectins and surfactant metabolism. Annu Rev Physiol 2001;63:495–519.PubMedCrossRefGoogle Scholar
  17. 17.
    Akiyama J, Hoffman A, Brown C, et al. Tissue distribution of surfactant proteins A and D in the mouse. J Histochem Cytochem 2002;50(7):993–996.PubMedGoogle Scholar
  18. 18.
    Lin Z, deMello D, Phelps DS, et al. Both human SP-A1 and SP-A2 genes are expressed in small and large intestine. Pediatr Pathol Mol Med 2001;20(5):367–386.PubMedCrossRefGoogle Scholar
  19. 19.
    Paananen R, Postle AD, Clark G, et al. Eustachian tube surfactant is different from alveolar surfactant: determination of phospholipid composition of porcine eustachian tube lavage fluid. J Lipid Res 2002;43(1):99–106.PubMedGoogle Scholar
  20. 20.
    Leth-Larsen R, Floridon C, Nielsen O, et al. Surfactant protein D in the female genital tract. Mol Hum Reprod 2004;10(3):149–154.PubMedCrossRefGoogle Scholar
  21. 21.
    Madsen J, Kliem A, Tornoe I, et al. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 2000;164(11):5866–5870.PubMedGoogle Scholar
  22. 22.
    Seifart C, Lin HM, Seifart U, et al. Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma. Clin Genet 2005;68(2):128–136.PubMedCrossRefGoogle Scholar
  23. 23.
    Kala P, Ten Have T, Nielsen H, et al. Association of pulmonary surfactant protein A (SP-A) gene and respiratory distress syndrome: interaction with SP-B. Pediatr Res 1998;43(2):169–177.PubMedCrossRefGoogle Scholar
  24. 24.
    Floros J, Fan R, Matthews A, et al. Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences. Clin Genet 2001;60(3):178–187.PubMedCrossRefGoogle Scholar
  25. 25.
    Lahti M, Lofgren J, Marttila R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002;51(6):696–699.PubMedGoogle Scholar
  26. 26.
    Guo X, Lin HM, Lin Z, et al. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001;18(3):482–490.PubMedCrossRefGoogle Scholar
  27. 27.
    Ramet M, Haataja R, Marttila R, et al. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet 2000;66(5):1569–1579.PubMedCrossRefGoogle Scholar
  28. 28.
    Lofgren J, Ramet M, Renko M, et al. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002;185(3):283–289.PubMedCrossRefGoogle Scholar
  29. 29.
    Korfhagen TR, Bruno MD, Ross GF, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci USA 1996;93(18):9594–9599.PubMedCrossRefGoogle Scholar
  30. 30.
    Korfhagen TR, LeVine AM, Whitsett JA. Surfactant protein A (SP-A) gene targeted mice. Biochim Biophys Acta 1998;1408(2–3):296–302.PubMedGoogle Scholar
  31. 31.
    LeVine AM, Gwozdz J, Stark J, et al. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999;103(7):1015–1021.PubMedCrossRefGoogle Scholar
  32. 32.
    LeVine AM, Hartshorn K, Elliott J, et al. Absence of SPA modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 2002;282(3):L563–L572.PubMedGoogle Scholar
  33. 33.
    LeVine AM, Kurak KE, Bruno MD, et al. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998;19(4):700–708.PubMedGoogle Scholar
  34. 34.
    LeVine AM, Kurak KE, Wright JR, et al. Surfactant protein-A binds group B Streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 1999;20(2):279–286.PubMedGoogle Scholar
  35. 35.
    Botas C, Poulain F, Akiyama J, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci USA 1998;95(20):11869–11874.PubMedCrossRefGoogle Scholar
  36. 36.
    Korfhagen TR, Sheftelyevich V, Burhans MS, et al. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J Biol Chem 1998;273(43):28438–28443.PubMedCrossRefGoogle Scholar
  37. 37.
    Wert S, Jones T, Korfhagen T, et al. Spontaneous emphysema in surfactant protein D gene-targeted mice. Chest 2000;117(5 Suppl 1):248S.PubMedCrossRefGoogle Scholar
  38. 38.
    Weaver TE, Conkright JJ. Function of surfactant proteins B and C. Annu Rev Physiol 2001;63:555–578.PubMedCrossRefGoogle Scholar
  39. 39.
    Whitsett JA, Ohning BL, Ross G, et al. Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy. Pediatr Res 1986;20(5):460–467.PubMedCrossRefGoogle Scholar
  40. 40.
    Whitsett JA, Weaver TE, Clark JC, et al. Glucocorticoid enhances surfactant proteolipid Phe and pVal synthesis and RNA in fetal lung. J Biol Chem 1987;262(32):15618–15623.PubMedGoogle Scholar
  41. 41.
    Ballard PL, Ertsey R, Gonzales LW, et al. Transcriptional regulation of human pulmonary surfactant proteins SP-B and SP-C by glucocorticoids. Am J Respir Cell Mol Biol 1996;14(6):599–607.PubMedGoogle Scholar
  42. 42.
    Venkatesh VC, Iannuzzi DM, Ertsey R, et al. Differential glucocorticoid regulation of the pulmonary hydrophobic surfactant proteins SP-B and SP-C. Am J Respir Cell Mol Biol 1993;8(2):222–228.PubMedGoogle Scholar
  43. 43.
    Bohinski RJ, Di Lauro R, Whitsett JA. The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 1994;14(9):5671–5681.PubMedGoogle Scholar
  44. 44.
    Margana R, Berhane K, Alam MN, et al. Identification of functional TTF-1 and Sp1/Sp3 sites in the upstream promoter region of rabbit SP-B gene. Am J Physiol Lung Cell Mol Physiol 2000;278(3):L477–L484.PubMedGoogle Scholar
  45. 45.
    Margana RK, Boggaram V. Functional analysis of surfactant protein B (SP-B) promoter. Sp1, Sp3, TTF-1, and HNF-3alpha transcription factors are necessary for lung cell-specific activation of SP-B gene transcription. J Biol Chem 1997;272(5):3083–3090.PubMedCrossRefGoogle Scholar
  46. 46.
    DeFelice M, Silberschmidt D, DiLauro R, et al. TTF-1 phosphorylation is required for peripheral lung morphogenesis, perinatal survival, and tissue-specific gene expression. J Biol Chem 2003;278(37):35574–35583.PubMedCrossRefGoogle Scholar
  47. 47.
    Wan H, Xu Y, Ikegami M, et al. Foxa2 is required for transition to air breathing at birth. Proc Natl Acad Sci USA 2004;101(40):14449–14454.PubMedCrossRefGoogle Scholar
  48. 48.
    Lin S, Perl AK, Shannon JM. Erm/thyroid transcription factor 1 interactions modulate surfactant protein C transcription. J Biol Chem 2006;281(24):16716–16726.PubMedCrossRefGoogle Scholar
  49. 49.
    Yang MC, Guo Y, Liu CC, et al. The TTF-1/TAP26 complex differentially modulates surfactant protein-B (SP-B) and-C (SP-C) promoters in lung cells. Biochem Biophys Res Commun 2006;344(2):484–490.PubMedCrossRefGoogle Scholar
  50. 50.
    Whitsett JA. Genes and transcriptional programs regulating alveolar homeostasis. Respirology 2006;11(Suppl 1):S11.CrossRefGoogle Scholar
  51. 51.
    Martis PC, Whitsett JA, Xu Y, et al. C/EBPalpha is required for lung maturation at birth. Development 2006;133(6):1155–11564.PubMedCrossRefGoogle Scholar
  52. 52.
    Farrell PM, Avery ME. Hyaline membrane disease. Am Rev Respir Dis 1975;111(5):657–688.PubMedGoogle Scholar
  53. 53.
    Brehier A, Rooney SA. Phosphatidylcholine synthesis and glycogen depletion in fetal mouse lung: developmental changes and the effects of dexamethasone. Exp Lung Res 1981;2(4):273–287.PubMedCrossRefGoogle Scholar
  54. 54.
    Pryhuber GS, Hull WM, Fink I, et al. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 1991;30(6):597–605.PubMedCrossRefGoogle Scholar
  55. 55.
    Ross GF, Ikegami M, Steinhilber W, et al. Surfactant protein C in fetal and ventilated preterm rabbit lungs. Am J Physiol 1999;277(6 Pt 1):L1104–L1108.PubMedGoogle Scholar
  56. 56.
    Yoshida I, Ban N, Inagaki N. Expression of ABCA3, a causative gene for fatal surfactant deficiency, is upregulated by glucocorticoids in lung alveolar type II cells. Biochem Biophys Res Commun 2004;323(2):547–555.PubMedCrossRefGoogle Scholar
  57. 57.
    Yamano G, Funahashi H, Kawanami O, et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett 2001;508(2):221–225.PubMedCrossRefGoogle Scholar
  58. 58.
    Zen K, Notarfrancesco K, Oorschot V, et al. Generation and characterization of monoclonal antibodies to alveolar type II cell lamellar body membrane. Am J Physiol 1998;275(1 Pt 1):L172–L183.PubMedGoogle Scholar
  59. 59.
    Khoor A, Gray ME, Hull WM, et al. Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J Histochem Cytochem 1993;41(9):1311–1319.PubMedGoogle Scholar
  60. 60.
    Khoor A, Stahlman MT, Gray ME, et al. Temporal-spatial distribution of SP-B and SP-C proteins and mRNAs in developing respiratory epithelium of human lung. J Histochem Cytochem 1994;42(9):1187–1199.PubMedGoogle Scholar
  61. 61.
    Ballard PL, Merrill JD, Godinez RI, et al. Surfactant protein profile of pulmonary surfactant in premature infants. Am J Respir Crit Care Med 2003;168(9):1123–1128.PubMedCrossRefGoogle Scholar
  62. 62.
    deMello DE, Phelps DS, Patel G, et al. Expression of the 35 kDa and low molecular weight surfactant-associated proteins in the lungs of infants dying with respiratory distress syndrome. Am J Pathol 1989;134(6):1285–1293.PubMedGoogle Scholar
  63. 63.
    Karcher R, Sykes E, Batton D, et al. Gestational age-specific predicted risk of neonatal respiratory distress syndrome using lamellar body count and surfactant-to-albumin ratio in amniotic fluid. Am J Obstet Gynecol 2005;193(5):1680–1684.PubMedCrossRefGoogle Scholar
  64. 64.
    Berkowitz GS, Chang K, Chervenak FA, et al. Decreasing frequency of iatrogenic neonatal respiratory distress syndrome. Am J Perinatol 1986;3(3):205–208.PubMedCrossRefGoogle Scholar
  65. 65.
    Hamvas A, Wise PH, Yang RK, et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. N Engl J Med 1996;334(25):1635–1640.PubMedCrossRefGoogle Scholar
  66. 66.
    Malloy MH, Freeman DH. Respiratory distress syndrome mortality in the United States, 1987 to 1995. J Perinatol 2000;20(7):414–420.PubMedCrossRefGoogle Scholar
  67. 67.
    Schwartz RM, Luby AM, Scanlon JW, et al. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 1994;330(21):1476–1480.PubMedCrossRefGoogle Scholar
  68. 68.
    Clark RH. The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. J Perinatol 2005;25(4):251–257.PubMedCrossRefGoogle Scholar
  69. 69.
    Angus DC, Linde-Zwirble WT, Clermont G, et al. Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. Am J Respir Crit Care Med 2001;164(7):1154–1160.PubMedGoogle Scholar
  70. 70.
    Pilot-Matias TJ, Kister SE, Fox JL, et al. Structure and organization of the gene encoding human pulmonary surfactant proteolipid SP-B. DNA 1989;8(2):75–86.PubMedGoogle Scholar
  71. 71.
    Vamvakopoulos NC, Modi WS, Floros J. Mapping the human pulmonary surfactant-associated protein B gene (SFTP3) to chromosome 2p12 → p11.2. Cytogenet Cell Genet 1995;68(1–2):8–10.PubMedCrossRefGoogle Scholar
  72. 72.
    Weaver TE. Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta 1998;1408(2–3):173–179.PubMedGoogle Scholar
  73. 73.
    Hawgood S. Surfactant protein B: structure and function. Biol Neonate 2004;85(4):285–289.PubMedCrossRefGoogle Scholar
  74. 74.
    Patthy L. Homology of the precursor of pulmonary surfactant-associated protein SP-B with prosaposin and sulfated glycoprotein 1. J Biol Chem 1991;266(10):6035–6037.PubMedGoogle Scholar
  75. 75.
    Wang G, Christensen ND, Wigdahl B, et al. Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease. Biochem J 2003;369(Pt 1):179–184.PubMedCrossRefGoogle Scholar
  76. 76.
    Lin Z, Wang G, Demello DE, et al. An alternatively spliced surfactant protein B mRNA in normal human lung: disease implication. Biochem J 1999;343Pt 1:145–149.PubMedCrossRefGoogle Scholar
  77. 77.
    Hawgood S, Latham D, Borchelt J, et al. Cell-specific posttranslational processing of the surfactant-associated protein SP-B. Am J Physiol 1993;264(3 Pt 1):L290–L299.PubMedGoogle Scholar
  78. 78.
    Nogee LM, de Mello DE, Dehner LP, et al. Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 1993;328(6):406–410.PubMedCrossRefGoogle Scholar
  79. 79.
    Schumacher RE, Marrogi AJ, Heidelberger KP. Pulmonary alveolar proteinosis in a newborn. Pediatr Pulmonol 1989;7(3):178–182.PubMedCrossRefGoogle Scholar
  80. 80.
    Moulton SL, Krous HF, Merritt TA, et al. Congenital pulmonary alveolar proteinosis: failure of treatment with extracorporeal life support. J Pediatr 1992;120(2 Pt 1):297–302.PubMedGoogle Scholar
  81. 81.
    Nogee LM, Garnier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994;93(4):1860–1863.PubMedCrossRefGoogle Scholar
  82. 82.
    Cole FS, Hamvas A, Rubinstein P, et al. Population-based estimates of surfactant protein B deficiency. Pediatrics 2000;105(3 Pt 1):538–541.PubMedCrossRefGoogle Scholar
  83. 83.
    Hamvas A, Trusgnich M, Brice H, et al. Population-based screening for rare mutations: high-throughput DNA extraction and molecular amplification from Guthrie cards. Pediatr Res 2001;50(5):666–668.PubMedCrossRefGoogle Scholar
  84. 84.
    Nogee LM. Alterations in SP-B and SP-C expression in neonatal lung disease. Annu Rev Physiol 2004;66:601–623.PubMedCrossRefGoogle Scholar
  85. 85.
    Tredano M, Cooper DN, Stuhrmann M, et al. Origin of the prevalent SFTPB indel g.1549C > GAA (121ins2) mutation causing surfactant protein B (SP-B) deficiency. Am J Med Genet A 2006;140(1):62–69.PubMedGoogle Scholar
  86. 86.
    Nogee LM, Wert SE, Proffit SA, et al. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 2000;161(3 Pt 1):973–981.PubMedGoogle Scholar
  87. 87.
    Ballard PL, Nogee LM, Beers MF, et al. Partial deficiency of surfactant protein B in an infant with chronic lung disease. Pediatrics 1995;96(6):1046–1052.PubMedGoogle Scholar
  88. 88.
    Dunbar AE, 3rd, Wert SE, Ikegami M, et al. Prolonged survival in hereditary surfactant protein B (SP-B) deficiency associated with a novel splicing mutation. Pediatr Res 2000;48(3):275–282.PubMedCrossRefGoogle Scholar
  89. 89.
    Li J, Ikegami M, Na CL, et al. N-terminally extended surfactant protein (SP) C isolated from SP-B-deficient children has reduced surface activity and inhibited lipopolysaccharide binding. Biochemistry 2004;43(13):3891–3898.PubMedCrossRefGoogle Scholar
  90. 90.
    Vorbroker DK, Profitt SA, Nogee LM, et al. Aberrant processing of surfactant protein C in hereditary SP-B deficiency. Am J Physiol 1995;268(4 Pt 1):L647–L656.PubMedGoogle Scholar
  91. 91.
    Brasch F, Ochs M, Kahne T, et al. Involvement of napsin A in the C-and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung. J Biol Chem 2003;278(49):49006–49014.PubMedCrossRefGoogle Scholar
  92. 92.
    Ueno T, Linder S, Na CL, et al. Processing of pulmonary surfactant protein B by napsin and cathepsin H. J Biol Chem 2004;279(16):16178–16184.PubMedCrossRefGoogle Scholar
  93. 93.
    Clark JC, Wert SE, Bachurski CJ, et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995;92(17):7794–7798.PubMedCrossRefGoogle Scholar
  94. 94.
    Stahlman MT, Gray MP, Falconieri MW, et al. Lamellar body formation in normal and surfactant protein B-deficient fetal mice. Lab Invest 2000;80(3):395–403.PubMedGoogle Scholar
  95. 95.
    Melton KR, Nesslein LL, Ikegami M, et al. SP-B deficiency causes respiratory failure in adult mice. Am J Physiol Lung Cell Mol Physiol 2003;285(3):L543–L549.PubMedGoogle Scholar
  96. 96.
    Clark JC, Weaver TE, Iwamoto HS, et al. Decreased lung compliance and air trapping in heterozygous SP-B-deficient mice. Am J Respir Cell Mol Biol 1997;16(1):46–52.PubMedGoogle Scholar
  97. 97.
    Tokieda K, Iwamoto HS, Bachurski C, et al. Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol 1999;21(4):463–472.PubMedGoogle Scholar
  98. 98.
    Liu W, Bentley CM, Floros J. Study of human SP-A, SP-B and SP-D loci: allele frequencies, linkage disequilibrium and heterozygosity in different races and ethnic groups. BMC Genet 2003;4(1):13.PubMedCrossRefGoogle Scholar
  99. 99.
    Lin Z, Pearson C, Chinchilli V, et al. Polymorphisms of human SP-A, SP-B, and SP-D genes: association of SP-B Thr131Ile with ARDS. Clin Genet 2000;58(3):181–191.PubMedCrossRefGoogle Scholar
  100. 100.
    Guo X, Lin HM, Lin Z, et al. Polymorphisms of surfactant protein gene A, B, D, and of SP-B-linked microsatellite markers in COPD of a Mexican population. Chest 2000;117(5 Suppl 1):249S–2450S.PubMedGoogle Scholar
  101. 101.
    Floros J, Veletza SV, Kotikalapudi P, et al. Dinucleotide repeats in the human surfactant protein-B gene and respiratory-distress syndrome. Biochem J 1995;305(Pt 2):583–590.PubMedGoogle Scholar
  102. 102.
    Thomas KH, Meyn P, Suttorp N. Single nucleotide polymorphism in 5′-flanking region reduces transcription of surfactant protein B gene in H441 cells. Am J Physiol Lung Cell Mol Physiol 2006;291(3):L386–L390.PubMedCrossRefGoogle Scholar
  103. 103.
    Floros J, Fan R, Diangelo S, et al. Surfactant protein (SP) B associations and interactions with SP-A in white and black subjects with respiratory distress syndrome. Pediatr Int 2001;43(6):567–576.PubMedCrossRefGoogle Scholar
  104. 104.
    Rova M, Haataja R, Marttila R, et al. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004;13(11):1095–1104.PubMedCrossRefGoogle Scholar
  105. 105.
    Haataja R, Ramet M, Marttila R, et al. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 2000;9(18):2751–2760.PubMedCrossRefGoogle Scholar
  106. 106.
    Ewis AA, Kondo K, Dang F, et al. Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers. Am J Ind Med 2006;49(5):367–373.PubMedCrossRefGoogle Scholar
  107. 107.
    Seifart C, Seifart U, Plagens A, et al. Surfactant protein B gene variations enhance susceptibility to squamous cell carcinoma of the lung in German patients. Br J Cancer 2002;87(2):212–217.PubMedCrossRefGoogle Scholar
  108. 108.
    Lin Z, Thomas NJ, Wang Y, et al. Deletions within a CA-repeat-rich region of intron 4 of the human SP-B gene affect mRNA splicing. Biochem J 2005;389(Pt 2):403–412.PubMedGoogle Scholar
  109. 109.
    Marttila R, Haataja R, Ramet M, et al. Surfactant protein B polymorphism and respiratory distress syndrome in premature twins. Hum Genet 2003;112(1):18–23.PubMedCrossRefGoogle Scholar
  110. 110.
    Selman M, Lin HM, Montano M, et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 2003;113(6):542–550.PubMedCrossRefGoogle Scholar
  111. 111.
    Hamvas A, Nogee LM, Mallory GB, Jr., et al. Lung transplantation for treatment of infants with surfactant protein B deficiency. J Pediatr 1997;130(2):231–239.PubMedCrossRefGoogle Scholar
  112. 112.
    Glasser SW, Korfhagen TR, Weaver TE, et al. cDNA, deduced polypeptide structure and chromosomal assignment of human pulmonary surfactant proteolipid, SPL(pVal). J Biol Chem 1988;263(1):9–12.PubMedGoogle Scholar
  113. 113.
    Conkright JJ, Bridges JP, Na CL, et al. Secretion of surfactant protein C, an integral membrane protein, requires the N-terminal propeptide. J Biol Chem 2001;276(18):14658–14664.PubMedCrossRefGoogle Scholar
  114. 114.
    Keller A, Eistetter HR, Voss T, et al. The pulmonary surfactant protein C (SP-C) precursor is a type II transmembrane protein. Biochem J 1991;277(Pt 2):493–499.PubMedGoogle Scholar
  115. 115.
    Curstedt T, Johansson J, Persson P, et al. Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. Proc Natl Acad Sci USA 1990;87(8):2985–2989.PubMedCrossRefGoogle Scholar
  116. 116.
    Vorbroker DK, Dey C, Weaver TE, et al. Surfactant protein C precursor is palmitoylated and associates with subcellular membranes. Biochim Biophys Acta 1992;1105(1):161–169.PubMedCrossRefGoogle Scholar
  117. 117.
    Sanchez-Pulido L, Devos D, Valencia A. BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci 2002;27(7):329–332.PubMedCrossRefGoogle Scholar
  118. 118.
    Beers MF, Mulugeta S. Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol 2005;67:663–696.PubMedCrossRefGoogle Scholar
  119. 119.
    Glasser SW, Burhans MS, Eszterhas SK, et al. Human SP-C gene sequences that confer lung epithelium-specific expression in transgenic mice. Am J Physiol Lung Cell Mol Physiol 2000;278(5):L933–L9345.PubMedGoogle Scholar
  120. 120.
    Glasser SW, Eszterhas SK, Detmer EA, et al. The murine SP-C promoter directs type II cell-specific expression in transgenic mice. Am J Physiol Lung Cell Mol Physiol 2005;288(4):L625–L632.PubMedCrossRefGoogle Scholar
  121. 121.
    Whitsett JA, Glasser SW, Tichelaar JW, et al. Transgenic models for study of lung morphogenesis and repair: Parker B. Francis lecture. Chest 2001;120(1 Suppl):27S–30S.PubMedCrossRefGoogle Scholar
  122. 122.
    Nogee LM, Dunbar AE, 3rd, Wert S, et al. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 2002;121(3 Suppl):20S–21S.PubMedCrossRefGoogle Scholar
  123. 123.
    Soraisham AS, Tierney AJ, Amin HJ. Neonatal respiratory failure associated with mutation in the surfactant protein C gene. J Perinatol 2006;26(1):67–70.PubMedCrossRefGoogle Scholar
  124. 124.
    Brasch F, Griese M, Tredano M, et al. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J 2004;24(1):30–39.PubMedCrossRefGoogle Scholar
  125. 125.
    Cameron HS, Somaschini M, Carrera P, et al. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr 2005;146(3):370–375.PubMedCrossRefGoogle Scholar
  126. 126.
    Hamvas A, Nogee LM, White FV, et al. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol 2004;30(6):771–776.PubMedCrossRefGoogle Scholar
  127. 127.
    Thomas AQ, Lane K, Phillips J, 3rd, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165(9):1322–1328.PubMedCrossRefGoogle Scholar
  128. 128.
    Lawson WE, Grant SW, Ambrosini V, et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004;59(11):977–980.PubMedCrossRefGoogle Scholar
  129. 129.
    Lahti M, Marttila R, Hallman M. Surfactant protein C gene variation in the Finnish population-association with perinatal respiratory disease. Eur J Hum Genet 2004;12(4):312–320.PubMedCrossRefGoogle Scholar
  130. 130.
    Setoguchi Y, Ikeda T, Fukuchi Y. Clinical features and genetic analysis of surfactant protein C in adult-onset familial interstitial pneumonia. Respirology 2006;11(Suppl 1):S41–S45.PubMedCrossRefGoogle Scholar
  131. 131.
    Nogee LM, Dunbar AE, 3rd, Wert SE, et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344(8):573–579.PubMedCrossRefGoogle Scholar
  132. 132.
    Tredano M, Griese M, Brasch F, et al. Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease. Am J Med Genet A 2004;126(1):18–26.CrossRefGoogle Scholar
  133. 133.
    Stevens PA, Pettenazzo A, Brasch F, et al. Nonspecific interstitial pneumonia, alveolar proteinosis, and abnormal proprotein trafficking resulting from a spontaneous mutation in the surfactant protein C gene. Pediatr Res 2005;57(1):89–98.PubMedCrossRefGoogle Scholar
  134. 134.
    Bridges JP, Wert SE, Nogee LM, et al. Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice. J Biol Chem 2003;278(52):52739–52746.PubMedCrossRefGoogle Scholar
  135. 135.
    Wang WJ, Russo SJ, Mulugeta S, et al. Biosynthesis of surfactant protein C (SP-C). Sorting of SP-C proprotein involves homomeric association via a signal anchor domain. J Biol Chem 2002;277(22):19929–199937.PubMedCrossRefGoogle Scholar
  136. 136.
    Wang WJ, Mulugeta S, Russo SJ, et al. Deletion of exon 4 from human surfactant protein C results in aggresome formation and generation of a dominant negative. J Cell Sci 2003;116(Pt 4):683–692.PubMedCrossRefGoogle Scholar
  137. 137.
    Glasser SW, Burhans MS, Korfhagen TR, et al. Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 2001;98(11):6366–6371.PubMedCrossRefGoogle Scholar
  138. 138.
    Glasser SW, Detmer EA, Ikegami M, et al. Pneumonitis and emphysema in sp-C gene targeted mice. J Biol Chem 2003;278(16):14291–14298.PubMedCrossRefGoogle Scholar
  139. 139.
    Ikegami M, Weaver TE, Conkright JJ, et al. Deficiency of SP-B reveals protective role of SP-C during oxygen lung injury. J Appl Physiol 2002;92(2):519–526.PubMedGoogle Scholar
  140. 140.
    Augusto L, Le Blay K, Auger G, et al. Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am J Physiol Lung Cell Mol Physiol 2001;281(4):L776–L785.PubMedGoogle Scholar
  141. 141.
    Augusto LA, Li J, Synguelakis M, et al. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem 2002;277(26):23484–23492.PubMedCrossRefGoogle Scholar
  142. 142.
    Chaby R, Garcia-Verdugo I, Espinassous Q, et al. Interactions between LPS and lung surfactant proteins. J Endotoxin Res 2005;11(3):181–185.PubMedGoogle Scholar
  143. 143.
    Mulugeta S, Nguyen V, Russo SJ, et al. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol 2005;32(6):521–530.PubMedCrossRefGoogle Scholar
  144. 144.
    Bridges JP, Xu Y, Na CL, et al. Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol 2006;172(3):395–407.PubMedCrossRefGoogle Scholar
  145. 145.
    Perlmutter DH. Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking. Pediatr Res 2002;52(6):832–836.PubMedGoogle Scholar
  146. 146.
    Zeitlin PL, Gail DB, Banks-Schlegel S. Protein processing and degradation in pulmonary health and disease. Am J Respir Cell Mol Biol 2003;29(5):642–645.PubMedCrossRefGoogle Scholar
  147. 147.
    Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001;42(7):1007–1017.PubMedGoogle Scholar
  148. 148.
    Connors TD, Van Raay TJ, Petry LR, et al. The cloning of a human ABC gene (ABC3) mapping to chromosome 16p13.3. Genomics 1997;39(2):231–234.PubMedCrossRefGoogle Scholar
  149. 149.
    Stefkova J, Poledne R, Hubacek JA. ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res 2004;53(3):235–243.PubMedGoogle Scholar
  150. 150.
    Knight BL. ATP-binding cassette transporter A1: regulation of cholesterol efflux. Biochem Soc Trans 2004;32(Pt 1):124–127.PubMedCrossRefGoogle Scholar
  151. 151.
    Brasch F, Schimanski S, Muhlfeld C, et al. Alteration of the pulmonary surfactant system in full-term infants with hereditary ABCA3 deficiency. Am J Respir Crit Care Med 2006;174(5):571–580.PubMedCrossRefGoogle Scholar
  152. 152.
    Garmany TH, Moxley MA, White FV, et al. Surfactant composition and function in patients with ABCA3 mutations. Pediatr Res 2006;59(6):801–805.PubMedCrossRefGoogle Scholar
  153. 153.
    Bullard JE, Wert SE, Whitsett JA, et al. ABCA3 Mutations Associated with Pediatric Interstitial Lung Disease. Am J Respir Crit Care Med 2005;172(8):1026–1031.PubMedCrossRefGoogle Scholar
  154. 154.
    Cheong N, Madesh M, Gonzales LW, et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem 2006;281(14):9791–9800.PubMedCrossRefGoogle Scholar
  155. 155.
    Matsumura Y, Ban N, Ueda K, Inagaki N. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J Biol Chem 2006;281(45):34503–34514.PubMedCrossRefGoogle Scholar
  156. 156.
    Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003;349(26):2527–2539.PubMedCrossRefGoogle Scholar
  157. 157.
    Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol 2002;34(1):23–29.PubMedCrossRefGoogle Scholar
  158. 158.
    Sharief N, Crawford OF, Dinwiddie R. Fibrosing alveolitis and desquamative interstitial pneumonitis. Pediatr Pulmonol 1994;17(6):359–365.PubMedCrossRefGoogle Scholar
  159. 159.
    Katzenstein AL, Gordon LP, Oliphant M, et al. Chronic pneumonitis of infancy. A unique form of interstitial lung disease occurring in early childhood. Am J Surg Pathol 1995;19(4):439–447.PubMedGoogle Scholar
  160. 160.
    Deterding R, Fan LL. Surfactant dysfunction mutations in children’s interstitial lung disease and beyond. Am J Respir Crit Care Med 2005;172(8):940–941.PubMedCrossRefGoogle Scholar
  161. 161.
    Amin RS, Wert SE, Baughman RP, et al. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr 2001;139(1):85–92.PubMedCrossRefGoogle Scholar
  162. 162.
    deMello DE, Heyman S, Phelps DS, et al. Ultrastructure of lung in surfactant protein B deficiency. Am J Respir Cell Mol Biol 1994;11(2):230–239.PubMedGoogle Scholar
  163. 163.
    Edwards V, Cutz E, Viero S, et al. Ultrastructure of lamellar bodies in congenital surfactant deficiency. Ultrastruct Pathol 2005;29(6):503–509.PubMedCrossRefGoogle Scholar
  164. 164.
    Cutz E, Wert SE, Nogee LM, et al. Deficiency of lamellar bodies in alveolar type II cells associated with fatal respiratory disease in a full-term infant. Am J Respir Crit Care Med 2000;161(2 Pt 1):608–614.PubMedGoogle Scholar
  165. 165.
    Tryka AF, Wert SE, Mazursky JE, et al. Absence of lamellar bodies with accumulation of dense bodies characterizes a novel form of congenital surfactant defect. Pediatr Dev Pathol 2000;3(4):335–345.PubMedCrossRefGoogle Scholar
  166. 166.
    Langston C, Patterson K, Dishop MK, et al. A protocol for the handling of tissue obtained by operative lung biopsy: recommendations of the chILD pathology cooperative group. Pediatr Dev Pathol 2006;9(3):173–180.PubMedCrossRefGoogle Scholar
  167. 167.
    Dirksen U, Nishinakamura R, Groneck P, et al. Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 1997;100(9):2211–2217.PubMedCrossRefGoogle Scholar
  168. 168.
    Robb L, Drinkwater CC, Metcalf D, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. 3 and 5. Proc Natl Acad Sci USA 1995;92(21):9565–9569.PubMedCrossRefGoogle Scholar
  169. 169.
    Nishinakamura R, Nakayama N, Hirabayashi Y, et al. Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal. Immunity 1995;2(3):211–222.PubMedCrossRefGoogle Scholar
  170. 170.
    Stanley E, Lieschke GJ, Grail D, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994;91(12):5592–5596.PubMedCrossRefGoogle Scholar
  171. 171.
    Dranoff G, Crawford AD, Sadelain M, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994;264(5159):713–716.PubMedCrossRefGoogle Scholar
  172. 172.
    Krude H, Schutz B, Biebermann H, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109(4):475–480.PubMedGoogle Scholar
  173. 173.
    Pohlenz J, Dumitrescu A, Zundel D, et al. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 2002;109(4):469–473.PubMedGoogle Scholar
  174. 174.
    Iwatani N, Mabe H, Devriendt K, et al. Deletion of NKX2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr 2000;137(2):272–276.PubMedCrossRefGoogle Scholar
  175. 175.
    Devriendt K, Vanhole C, Matthijs G, et al. Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338(18):1317–1318.PubMedCrossRefGoogle Scholar
  176. 176.
    Moya CM, Perez de Nanclares G, Castano L, et al. Functional study of a novel single deletion in the TITF1/NKX2.1 homeobox gene that produces congenital hypothyroidism and benign chorea but not pulmonary distress. J Clin Endocrinol Metab 2006;91(5):1832–1841.PubMedCrossRefGoogle Scholar
  177. 177.
    Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958;258(23):1123–1142.PubMedCrossRefGoogle Scholar
  178. 178.
    Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002;166(2):215–235.PubMedCrossRefGoogle Scholar
  179. 179.
    Kogishi K, Kurozumi M, Fujita Y, et al. Isolation and partial characterization of human low molecular weight protein associated with pulmonary surfactant. Am Rev Respir Dis 1988;137(6):1426–1431.PubMedGoogle Scholar
  180. 180.
    Strong P, Kishore U, Morgan C, et al. A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. J Immunol Methods 1998;220(1-2):139–149.PubMedCrossRefGoogle Scholar
  181. 181.
    Bonfield TL, Russell D, Burgess S, et al. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis. Am J Respir Cell Mol Biol 2002;27(4):481–486.PubMedGoogle Scholar
  182. 182.
    Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;162(2 Pt 1):658–662.PubMedGoogle Scholar
  183. 183.
    Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190(6):875–880.PubMedCrossRefGoogle Scholar
  184. 184.
    Borsani G, Bassi MT, Sperandeo MP, et al. SLC7A7, encoding a putative permease-related protein, is mutated in patients with lysinuric protein intolerance. Nat Genet 1999;21(3):297–301.PubMedCrossRefGoogle Scholar
  185. 185.
    Sperandeo MP, Bassi MT, Riboni M, et al. Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance. Am J Hum Genet 2000;66(1):92–99.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Lawrence M. Nogee
    • 1
  • Susan E. Wert
    • 2
  1. 1.Department of PediatricsJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Department of Pediatrics, Division of Neonatology and Pulmonary BiologyThe University of Cincinnati College of Medicine and Cincinnati Children’s Hospital Medical CenterCincinnatiUSA

Personalised recommendations